Reduction of circulating soluble Flt‐1 alleviates preeclampsia‐like symptoms in a mouse model
Open Access
- 1 June 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (6b), 1857-1867
- https://doi.org/10.1111/j.1582-4934.2009.00820.x
Abstract
Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, glomeruloendotheliosis and elevated soluble Flt-1 (sFlt-1), a natural occurring antagonist of vascular endothelial growth factor (VEGF). Cancer patients receiving anti-VEGF therapy exhibit similar symptoms. We suggested that a decrease in circulating sFlt-1 would alleviate the symptoms associated with PE. Adenoviral (Adv) overexpression of sFlt-1 induced proteinuria, caused glomerular damage and increase in blood pressure in female Balb/c mice. Circulating level of sFlt-1 above 50 ng/ml plasma induced severe vascular damage and glomerular endotheliosis. Albumin concentration in urine was elevated up to 30-fold, compared to control AdvGFP-treated animals. The threshold of kidney damage was in the range of 20–30 ng/ml sFlt-1 in plasma (8–15 ng/ml in urine). Co-administration of AdvsFlt-1 with AdvVEGF to neutralize circulating sFlt-1 resulted in more than a 70% reduction in free sFlt-1 in plasma, more than 80% reduction in urine and rescued the damaging effect of sFlt-1 on the kidneys. This demonstrates that below a critical threshold sFlt-1 fails to elicit damage to the fenestrated endothelium and that co-expression of VEGF is able to rescue effects mediated by sFlt-1 overexpression.Keywords
This publication has 45 references indexed in Scilit:
- VEGF and TGF-β are required for the maintenance of the choroid plexus and ependymaThe Journal of Experimental Medicine, 2008
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of PreeclampsiaHypertension, 2007
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factorAmerican Journal of Obstetrics and Gynecology, 2007
- Corneal avascularity is due to soluble VEGF receptor-1Nature, 2006
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaNew England Journal of Medicine, 2006
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Pre-eclampsiaThe Lancet, 2005
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004